A Solution to the Dilution: The Role for Biomarkers in Advanced Ovarian Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31672769.
- Also identified by DOI 10.1158/1078-0432.CCR-19-3072 and PMC identifier 6942626.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.<i>See related article by Heitz et al., p. 213</i>.
Medical subject headings
- Carcinoma, Ovarian Epithelial
- Ovarian Neoplasms